These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38837043)

  • 1. The impact of testosterone-lowering medication on recidivism in individuals convicted of sexual offenses.
    Sauter J; Lingenti LM; Rettenberger M; Turner D; Briken P; Voß T
    Dialogues Clin Neurosci; 2024; 26(1):28-37. PubMed ID: 38837043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses.
    Sauter J; Turner D; Briken P; Rettenberger M
    Sex Abuse; 2021 Jun; 33(4):475-500. PubMed ID: 32167420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey on the Prescription Patterns of Pharmacological Agents in Individuals Who Have Committed Sexual Offenses During Forensic Outpatient Treatment in Germany: How Many Discontinue Testosterone Lowering Medication Under Parole?
    Sauter J; Rettenberger M; Briken P; Turner D
    J Sex Med; 2022 Jul; 19(7):1147-1155. PubMed ID: 35624071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing or stopping testosterone-lowering medication in men convicted of sexual offenses: clinical evaluation of the COSTLow-R Scale.
    Wolba J; Tozdan S; Briken P; Freese R; Retz W; Turner D
    J Sex Med; 2023 Mar; 20(4):549-558. PubMed ID: 36861326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for those who have sexually offended or are at risk of offending.
    Khan O; Ferriter M; Huband N; Powney MJ; Dennis JA; Duggan C
    Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD007989. PubMed ID: 25692326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathy and treatment outcome: Results from a sexual violence reduction program.
    Sewall LA; Olver ME
    Personal Disord; 2019 Jan; 10(1):59-69. PubMed ID: 29927298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Quasi-Experimental Evaluation of High-Intensity Inpatient Sex Offender Treatment in the Netherlands.
    Smid WJ; Kamphuis JH; Wever EC; Van Beek DJ
    Sex Abuse; 2016 Aug; 28(5):469-85. PubMed ID: 24867416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recidivism rates of female sexual offenders are low: a meta-analysis.
    Cortoni F; Hanson RK; Coache MÈ
    Sex Abuse; 2010 Dec; 22(4):387-401. PubMed ID: 21098822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To Reoffend or Not to Reoffend? An Investigation of Recidivism Among Individuals With Sexual Offense Histories and Psychopathy.
    Leung PC; Looman J; Abracen J
    Sex Abuse; 2021 Feb; 33(1):88-113. PubMed ID: 31538857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways for VA and community stakeholder management of military veterans with sexual offenses: Sexual and nonsexual recidivism rates and risk factors in military veterans released from California sexually violent predator (SVP) commitment.
    Sreenivasan S; Azizian A; Brooks Holliday S; Tsai J; Lockhart J; DiCiro M; Rokop J
    Psychol Serv; 2024 May; 21(2):317-327. PubMed ID: 37470993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field measures of psychopathy and sexual deviance as predictors of recidivism among sexual offenders.
    Harris PB; Boccaccini MT; Rice AK
    Psychol Assess; 2017 Jun; 29(6):639-651. PubMed ID: 28594208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actuarial risk assessment of sexual offenders: The psychometric properties of the Sex Offender Risk Appraisal Guide (SORAG).
    Rettenberger M; Rice ME; Harris GT; Eher R
    Psychol Assess; 2017 Jun; 29(6):624-638. PubMed ID: 28594206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting relapse: a meta-analysis of sexual offender recidivism studies.
    Hanson RK; Bussière MT
    J Consult Clin Psychol; 1998 Apr; 66(2):348-62. PubMed ID: 9583338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 24-Year Follow-up Study on Recidivism in Male Mentally Disordered Sexual Offenders With and Without Psychotic Disorders.
    Baudin C; Nilsson T; Wallinius M; Sturup J; Andiné P
    J Forensic Sci; 2020 Sep; 65(5):1610-1618. PubMed ID: 32311773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Leuprolide Acetate in the Management of High-Risk Sex Offenders.
    Gallo A; Abracen J; Looman J; Jeglic E; Dickey R
    Sex Abuse; 2019 Dec; 31(8):930-951. PubMed ID: 30047834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex offender treatment outcome, actuarial risk, and the aging sex offender in Canadian corrections: a long-term follow-up.
    Olver ME; Nicholaichuk TP; Gu D; Wong SC
    Sex Abuse; 2013 Aug; 25(4):396-422. PubMed ID: 23136142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A field study of acute dynamic risk assessment in individuals convicted of sexual offenses.
    Nitsche K; Etzler S; Balas J; Eher R; Rettenberger M
    Psychol Assess; 2022 Jun; 34(6):583-594. PubMed ID: 35298221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of serious violent offenders with psychotic illness and cognitive disorder dealt with by the New South Wales criminal justice system.
    Nielssen O; Yee NY; Dean K; Large M
    Aust N Z J Psychiatry; 2019 May; 53(5):441-446. PubMed ID: 29756478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective strengths, risk, and recidivism in a sample of known sexual offenders.
    Miller HA
    Sex Abuse; 2015 Feb; 27(1):34-50. PubMed ID: 25567534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.